Exponent, Inc.

  • Market Cap: Small Cap
  • Industry: Construction
  • ISIN: US30214U1025
USD
74.25
1.03 (1.41%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Exponent, Inc. stock-summary
stock-summary
Exponent, Inc.
Construction
Exponent, Inc. (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health. Its Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, statistical and data sciences, thermal sciences and vehicle analysis services. Its Environmental and Health segment includes chemical regulation and food safety; ecological and biological sciences; environmental and earth sciences, and health sciences. Exponent serves clients in automotive, government, health, insurance, manufacturing and technology, among others.
Company Coordinates stock-summary
Company Details
149 Commonwealth Dr , MENLO PARK CA : 94025-1133
stock-summary
Tel: 1 650 3269400
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 86 Schemes (43.19%)

Foreign Institutions

Held by 141 Foreign Institutions (10.8%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Dr. Paul Johnston
Chairman of the Board
Dr. Catherine Corrigan
President, Chief Executive Officer, Director
Dr. John Shoven
Lead Independent Director
Mr. George Brown
Director
Ms. Carol Lindstrom
Independent Director
Ms. Karen Richardson
Independent Director
Ms. Debra Zumwalt
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
142 Million
(Quarterly Results - Jun 2025)
Net Profit:
27 Million
stock-summary
Industry

Construction

stock-summary
Market cap

USD 4,551 Million (Small Cap)

stock-summary
P/E

54.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.32%

stock-summary
Debt Equity

-0.53

stock-summary
Return on Equity

18.32%

stock-summary
Price to Book

10.64